Christine Durand

Associate Professor


Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christine Durand is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus

Bae, S., Durand, C. M., Garonzik-Wang, J. M., Chow, E. K. H., Kucirka, L. M., McAdams-DeMarco, M. A., Massie, A. B., Al Ammary, F., Coresh, J. & Segev, D. L., Jan 1 2020, (Accepted/In press) In : Transplantation. p. 1294-1303 10 p.

Research output: Contribution to journalArticle

  • Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results

    Durand, C. M., Werbel, W., Doby, B., Brown, D., Desai, N. M., Malinis, M., Price, J., Chin-Hong, P., Mehta, S., Friedman-Moraco, R., Turgeon, N. A., Gilbert, A., Morris, M. I., Stosor, V., Elias, N., Aslam, S., Santos, C. A. Q., Hand, J. M., Husson, J., Pruett, T. L. & 14 others, Agarwal, A., Adebiyi, O., Pereira, M., Small, C. B., Apewokin, S., Heun Lee, D., Haidar, G., Blumberg, E., Mehta, S. A., Huprikar, S., Florman, S. S., Redd, A. D., Tobian, A. A. R. & Segev, D. L., Feb 1 2020, In : American Journal of Transplantation. 20, 2, p. 617-619 3 p.

    Research output: Contribution to journalLetter

    Open Access

    Early impact of COVID-19 on transplant center practices and policies in the United States

    Boyarsky, B. J., Po-Yu Chiang, T., Werbel, W. A., Durand, C. M., Avery, R. K., Getsin, S. N., Jackson, K. R., Kernodle, A. B., Van Pilsum Rasmussen, S. E., Massie, A. B., Segev, D. L. & Garonzik, J., Jul 1 2020, In : American Journal of Transplantation. 20, 7, p. 1809-1818 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

    Liu, R., Yeh, Y. H. J., Varabyou, A., Collora, J. A., Sherrill-Mix, S., Conover Talbot, C., Mehta, S., Albrecht, K., Hao, H., Zhang, H., Pollack, R. A., Beg, S. A., Calvi, R. M., Hu, J., Durand, C. M., Ambinder, R. F., Hoh, R., Deeks, S. G., Chiarella, J., Spudich, S. & 4 others, Douek, D. C., Bushman, F. D., Pertea, M. & Ho, Y. C., May 13 2020, In : Science translational medicine. 12, 543, eaaz0802.

    Research output: Contribution to journalArticle

    Open Access
  • Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: the BMT CTN-0903/AMC-080 Trial

    Ambinder, R. F., Wu, J., Logan, B., Durand, C., Shields, R., Popat, U. R., Little, R. F., McMahon, D. K., Cyktor, J., Mellors, J. W., Ayala, E., Kaplan, L. D., Noy, A., Jones, R. J., Howard, A., Forman, S. J., Porter, D., Arce-Lara, C., Shaughnessy, P., Sproat, L. & 5 others, Hashmi, S. K., Mendizabal, A. M., Horowitz, M. M., Navarro, W. H. & Alvarnas, J. C., Jan 1 2019, In : Biology of Blood and Marrow Transplantation.

    Research output: Contribution to journalArticle